Meredith Regan
Overview
Explore the profile of Meredith Regan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1512
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakhlis F, Niman S, Ueno N, Troll E, Ryan S, Yeh E, et al.
Breast Cancer Res Treat
. 2023 Dec;
204(2):289-297.
PMID: 38155272
Purpose: Many stage III inflammatory breast cancer (IBC) patients experience a sufficient response to first-line (1L) neoadjuvant chemotherapy (NAC) to allow surgery, while some require additional NAC. We evaluated the...
2.
Hertz D, Kidwell K, Douglas J, Viale G, Leyland-Jones B, Regan M, et al.
Pharmacogenomics
. 2020 Jul;
21(13):899-902.
PMID: 32723153
No abstract available.
3.
Sweeney C, Nakabayashi M, Regan M, Xie W, Hayes J, Keating N, et al.
J Natl Cancer Inst
. 2015 Sep;
107(12):djv261.
PMID: 26409187
New systemic therapies have prolonged the lives of men with metastatic castration-resistant prostate cancer (mCRPC). Use of these therapies in the adjuvant setting when the disease may be micrometastatic and...
4.
Goldhirsch A, Colleoni M, Regan M
Ecancermedicalscience
. 2015 Jun;
9:544.
PMID: 26082801
Results from two randomised global trials (SOFT & TEXT) designed to newly define the most effective components of adjuvant endocrine therapy for premenopausal women with endocrine responsive disease, showed that...
5.
Pignon J, Grisanzio C, Carvo I, Werner L, Regan M, Wilson E, et al.
PLoS One
. 2015 May;
10(5):e0128489.
PMID: 26024527
There is evidence that stem cells and their progeny play a role in the development of the prostate. Although stem cells are also considered to give rise to differentiated progeny...
6.
Rae J, Leyland-Jones B, Regan M, Thompson A
J Natl Cancer Inst
. 2015 Mar;
107(5).
PMID: 25814445
No abstract available.
7.
Rae J, Leyland-Jones B, Regan M
J Natl Cancer Inst
. 2014 Apr;
106(5).
PMID: 24700799
No abstract available.
8.
Rae J, Regan M, Leyland-Jones B, Hayes D, Dowsett M
J Clin Oncol
. 2013 Jun;
31(21):2753-5.
PMID: 23775974
No abstract available.
9.
Kazer M, Bailey Jr D, Chipman J, Psutka S, Hardy J, Hembroff L, et al.
BJU Int
. 2012 Sep;
111(3 Pt B):E84-91.
PMID: 22985348
Unlabelled: Study Type - Therapy (attitude prevalence) Level of Evidence 2a What's known on the subject? and What does the study add? Marked differences in uncertainty among patients have been...
10.
Dowsett M, Nielsen T, AHern R, Bartlett J, Coombes R, Cuzick J, et al.
J Natl Cancer Inst
. 2011 Oct;
103(22):1656-64.
PMID: 21960707
Uncontrolled proliferation is a hallmark of cancer. In breast cancer, immunohistochemical assessment of the proportion of cells staining for the nuclear antigen Ki67 has become the most widely used method...